Don’t just take our word for it...
We provide the highest quality partnering and strategy events that delivery the knowledge and connects our clients value.
Find out below why so many executives choose to attend LSX partnering events around the world.
Eli Lilly has been a proud sponsor and supporter of LSX for over 8 years. Over that time, our engagement with LSX has evolved into a trusted partnership which helps us connect with innovative and exciting life science companies in Europe and the US. Their team creates events and programs that are consistently high quality and provide valuable opportunities for partnering and learning. The team at LSX is a “go to” resource as we evolve and execute our business development strategy. I highly recommend them to all my life science colleagues!
David Linson, Sr Director-Business Development Strategic Operations & Intelligence, Eli Lilly & Company
We were delighted to be part of a fantastic evening and share in the successes of our industry. Thank you for putting such a great concept in place.
Dr. Matthias Müllenbeck, SVP, Head Global Business Development & Alliance Management, Merck KGaA
Great discussion and good networking. I will be back next year!
Søren Møller, Managing Partner, Novo holdings
Your platform is by far the best and most efficient, user-friendly and powerful platform I have ever used for a virtual conference. The filtering system works perfectly. The data is entered correctly (don't take this for granted) and the logic is programmed correctly.
Moshe Lebowitz, CEO, Healables Digital Health
A brilliant event for connecting with early-stage healthcare start-ups and other investors across Europe. The interesting format made it easy to switch between company presentations, 1:1’s and networking, making it a highly dynamic and productive event.
Eleanor Price, Investment Analyst, Thuja Capital
This was my second LSX conference following the LSX in London. Both have been incredibly enjoyable and have provided us with relevant industry connections, as well as helping introduce us to some of the brightest companies across different sectors.
Dafydd Prole, Investment Associate, Hanover 16
LSX is the not-to-miss event. The slogan promises networking with life science executives, pharma and investors. It does not disappoint. 60% attendees are investors and pharma companies. 25-30% innovators. Great ratio for start-ups looking for funding, partners.
Pilar Hermida, CEO, i-expand